✦ LIBER ✦

New perspectives in the management of non-small cell lung cancer (NSCLC): Gefitinib (Iressa, ZD 1839)

✍ Scribed by C. Manegold

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib (ZD1839): Therapy in selected

✍ Dongiovanni, Diego; Daniele, Lorenzo; Barone, Carla; Dongiovanni, Vincenzo; Fiss 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Commentary on ZD1839 (Iressa) in non sma

✍ Ranson, M.; Thatcher, N. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P-617 Gefitinib (ZD 1839, Iressa) as a l

✍ Haringhuizen, Annebeth; Vaessen, Heleen F.R.; Baas, Paul; van Zandwijk, Nico 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Gefitinib (ZD1839, Iressa®) in non-small

✍ Fabrice Barlési; Cécile Tchouhadjian; Christophe Doddoli; Patrick Villani; Laure 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

New hope for patients with non-small-cel

✍ Glenwood Goss 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 43 KB

P-620 Gefitinib (‘Iressa’, ZD1839) monot

✍ Park, Jinny; Park, Byeong-Bae; Lee, Se-Hoon; Park, Se Hoon; Lee, Kyung-Eun; Lee, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB